Drug Type Small molecule drug |
Synonyms Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, 盐酸西替利嗪/盐酸伪麻黄碱, Zyrtec-D + [1] |
Action antagonists, agonists |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists), α-adrenergic receptor agonists(Alpha adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (10 Aug 2001), |
Regulation- |
Molecular FormulaC10H16ClNO |
InChIKeyBALXUFOVQVENIU-KXNXZCPBSA-N |
CAS Registry345-78-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | China | 30 Dec 2005 | |
Perennial allergic rhinitis with seasonal variation | United States | 10 Aug 2001 |